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Abstract 
Nitrate and nitrite molecules are involved in the synthesis of nitric oxide (NO), a gaseous 
vasodilatory molecule, via the nitrate-nitrite-NO pathway. Oral bacteria are responsible for 
the reduction of nitrate to nitrite making them important regulators in NO production and 
vascular control. This paper aimed to investigate whether a laboratory-made propolis 
mouthwash maintained the oral nitrate reducing capacity (ONRC) of commensal bacteria 
compared with a chlorhexidine (CHX) mouthwash and the effects of this on vascular function 
in healthy individuals. Twenty-eight healthy participants visited the laboratory on two 
occasions where anthropometric, ONRC, blood pressure and vascular function data were 
collected. Between laboratory visits a CHX mouthwash or a propolis mouthwash were used 
for seven days, twice-daily. It was found that propolis mouthwash used for seven days 
maintained the ONRC of commensal bacteria in healthy individuals (pre; 343.4 ±251.8µM vs 
post; 331.9 ±225.1µM, p=0.71) and that CHX mouthwash significantly abolished this activity, 
lowering levels by 67.7% in seven days (pre; 399.7 ±356.4µM vs post; 129.1 ±171.3µM, 
p<0.001). No significant changes in blood pressure or vascular function were seen following 
mouthwash use despite bacterial changes. It is unclear whether these insignificant findings 
are down to methodological issues or external physiological pathways. It was concluded that 
propolis mouthwash and CHX mouthwash affect the ONRC of commensal bacteria 
differently. Propolis mouthwash seems to preserve the ONRC therefore is less detrimental to 
the oral microbiome than CHX mouthwash suggesting potential uses in dentistry and as a 
therapeutic for hypertensive individuals.  
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Nitric oxide (NO) is a small gaseous molecule which has many physiological roles in 
the body including acting as a potent vasodilator, making it essential for normalising 
blood pressure and vascular control (Archer, 1993; Stauss & Persson, 2000). NO 
can be produced by different routes including the nitrate-nitrite-NO pathway. 
Research into this pathway discovered that the interaction between nitrate and nitrite 
in the oral cavity can form NO in the blood and tissues (Lundberg, Weitzberg & 
Gladwin, 2008). Around 25% of dietary nitrate, from sources such as green leafy 
vegetables, is extracted into the salivary glands and taken to the oral cavity to be 
reduced to nitrite by commensal anaerobic bacteria. Swallowed saliva will enter the 
acidic environment of the stomach providing optimal conditions for nitrite reduction to 
NO (Lundberg et al, 1994). Mammals including humans lack the specific enzymes 
needed to reduce nitrate in the oral cavity. Therefore, a symbiotic relationship is 
seen with oral commensal bacteria which contribute to NO production and thus 
vascular control in humans whilst humans provide nitrate for these bacteria to respire 
(Lundberg, Weitzberg & Gladwin, 2008).  
Antiseptic mouthwash containing chlorhexidine (CHX) is widely used because it 
decreases the growth of harmful bacteria in the oral cavity. However, it can also 
hinder the growth and activity of other oral bacterial species in the microbiota 
including commensal nitrate-reducing bacteria (Petersson et al, 2009). As a result, 
mouthwash containing CHX is shown to raise blood pressure which is possibly down 
to eradicating these nitrate-reducing bacteria and therefore disrupting the nitrate-
nitrite-NO production pathway (Bryan, Tribble & Angelov, 2017; Kapil et al, 2013). 
Furthermore, blood pressure reduction has been shown following nitrate 
supplementation confirming that the pathway has implications in vascular control 
(Kapil et al, 2010). This may be particularly important as hypertension affects more 
than 1 in 4 people in the UK and can lead to an array of additional health problems 
like heart disease and stroke (Public Health England, 2017). Perhaps by increasing 
nitrate and nitrite bioavailability or allowing nitrate-reducing oral bacteria to colonise, 
blood pressure can be normalised through NO production, helping manage 
hypertension without the reliance on medication (Bryan, Tribble & Angelov, 2017).  
Propolis is a substance naturally made by bees to protect and repair their hives. It is 
composed of resins, waxes, fatty acids, aromatic oil, some flavonoids, minerals and 
vitamins (Khurshid et al, 2017; Wiȩckiewicz et al, 2013). Propolis has shown 
potential uses in medicine and dentistry due to its anti-bacterial properties. Studies 
have shown it to be as effective as CHX mouthwash at reducing plaque growth and 
improving the gingival index whilst showing a slightly better improvement in 
inflammation than CHX mouthwash (Dodwad & Kukreja, 2011). Propolis has also 
presented anti-fungal, anti-viral and anti-inflammatory properties (Khurshid et al, 
2017). Mouthwashes containing propolis are available to buy, however, it seems 
unknown in the literature whether propolis mouthwash can preserve the nitrate-
reducing activity of oral bacteria and the effects of this on an individual’s 
cardiovascular health, unlike CHX mouthwash which seems detrimental to these 
measures. Therefore, this paper aims to investigate whether a laboratory-made 
propolis mouthwash can maintain the oral nitrate reducing capacity (ONRC) of 
commensal bacteria when compared with CHX mouthwash and the effects of this on 
vascular function in healthy individuals. It is hypothesised that those using a propolis 
mouthwash for seven days will have a preserved ONRC and a lowered or 




normalised blood pressure whilst those using CHX mouthwash will show a reduction 
in ONRC and a rise in blood pressure.  
Methodology 
Study population 
Sixteen healthy participants were recruited from the University of Plymouth to 
complete this study. Participants gave written informed consent prior to the study. 
Questionnaires were completed by participants to ensure they were not already 
using mouthwash and that there were no allergies to propolis. Forty-eight hour 
dietary recalls were completed so similar meal compositions could be had prior to 
both laboratory visits as it is known that diet can influence oral nitrate and nitrite 
levels (Ashworth et al, 2019). Ethical approval was granted by the University of 
Plymouth Faculty of Health and Human Sciences Research Ethics Committee.  
Protocol  
Participants visited the Nutrition, Exercise and Health laboratories on two separate 
occasions. During the first visit, participants arrived in the morning under fasted 
conditions and baseline measures were collected. A ten millilitre (ml) mouth rinse 
containing nitrate and water was held in the participant’s mouth for five minutes and 
collected back into a falcon tube. This sample was analysed to determine how much 
nitrate was reduced to nitrite by the participant’s oral bacteria which shows the 
ONRC.  
Following this, basic anthropometric measures were collected including height, 
weight, BMI and body fat percentage using the Tanita body composition analyser 
(TBF-300 MA, Tokyo, Japan). Systolic blood pressure (SBP), diastolic blood 
pressure (DBP), mean arterial pressure (MAP) and heart rate (HR) data were 
recorded in a supine position. Three measures were taken after an initial 10 minute 
adaption period to obtain an average value using a sphygmomanometer (ProBP 
3400, Welch Allyn, New York, USA). Vascular function was measured using a near-
infrared spectroscopy (NIRS) device in combination with a reactive hyperaemia test 
(NIRO-200NX, Hamamatsu City, Japan). This involved a cuff being attached to a 
participant’s upper left arm and a NIRS probe being attached further down the arm to 
measure changes in light absorption at different wavelengths so that blood flow and 
oxygen levels could be monitored throughout the test (Soares & Murias, 2018). The 
reactive hyperaemia test consisted of baseline levels being measured for two 
minutes then the cuff expanding for five minutes to restrict blood flow to the tissues 
at a pressure of 200mmHg (occlusion stage) and then deflating for another five 
minutes (recovery stage). The NIRS device provided data on the tissue oxygenation 
index (TOI_1) throughout each test which was used for analysis. This value displays 
the percentage of blood oxygenated in the tissues.  
Once baseline data had been collected, participants received fourteen tubes of ten 
ml mouthwash to be used twice a day over a seven day period. Instructions for 
mouthwash use were given to participants ensuring the correct procedure was being 
followed. Instructions included rinsing the mouth for one minute twice-daily for seven 
days and not rinsing the mouth with water for five minutes after use. The distribution 
of CHX and propolis mouthwash was randomised and double blind. Following the 
seven day interval, participants returned to the lab under the same fasted conditions 
and data collection was repeated. 





Storage of ONRC samples 
The ONRC samples collected were centrifuged at 14 000 rpm for 10 minutes at 4°C 
and were then transferred into eppendorf tubes. All samples were labelled with 
participant codes to maintain confidentiality, the trial number, what the sample was, 
and the date collected. Samples were frozen at -80°C until needed for analysis.  
Preparation of mouthwashes 
The mouthwashes used in this study were either Corsodyl, a commercial CHX based 
antiseptic mouthwash (Corsodyl, GlaxoSmithKline, Middlesex, England) or a propolis 
mouthwash which was made in the laboratory. For this, crude propolis was ground 
into a fine powder and mixed with 95% ethanol. The solution was shaken using a 
magnetic stirrer for 72 hours at 20°C and filtered using filter paper. The extraction 
was centrifuged at 3 500 rpm for 10 minutes at 4°C and filtered again. A rotary 
evaporator was used to extract the ethanol from the solution at 60°C with low 
pressure. Water was added to achieve a dilution of 2.5% propolis within the solution. 
The resulting product was separated into 10ml falcon tubes and stored at -20°C until 
use. For the purpose of this paper, the CHX based mouthwash is named ‘CHX’ and 
the propolis mouthwash is named ‘PRO’. 
Analysis  
ONRC 
The ONRC nitrite concentrations in saliva were measured using High-Performance 
Liquid Chromatography (HPLC) by a Nitric Oxide analyser (ENO-30, Eicom, Japan). 
The nitrite values were displayed as microvolts (mv) and converted to micromoles 
(µM) for statistical analysis. 
Statistical analysis  
Statistical analysis was performed using Minitab® 19 Statistical Software (Minitab 
LLC, USA). Paired t tests were used to compare ONRC, blood pressure and 
vascular function (TOI_1) differences within treatment groups, before and after 
mouthwash use. Independent t tests were used to compare values between the two 
mouthwash groups. The data was logged, or a Mann Whitney U non-parametric test 
was used where data wasn’t normally distributed. Statistical significance was set at 
p<0.05.  
Results 
Participant baseline characteristics  
The data from the current study (sixteen participants) was combined with another 
group’s data (twelve participants) to maximise sample size who followed the same 
protocol as described above. Table 1 displays all participant baseline characteristics. 
Subjects in CHX and PRO groups had similar characteristics except those in CHX 
had a significantly higher baseline DBP compared to PRO (66.0 ±7.8mmHg vs 60.8 
±3.9mmHg respectively, p=0.04).  
 
 





Effects of mouthwash treatments on salivary ONRC 
Table 2 demonstrates that following a seven day period of using propolis mouthwash 
twice-daily, the ONRC of commensal bacteria post treatment is unchanged 
compared to baseline values (343.4 ±251.8µM vs 331.9 ±225.1µM respectively, 
p=0.71). In comparison, the ONRC of subjects using CHX mouthwash for the same 
amount of time was significantly attenuated by 67.7% compared to baseline values 
(129.1 ±171.3µM vs 399.7 ±356.4µM respectively, p<0.001). Figure 1 displays the 
significant differences in bacterial ONRC between mouthwash groups following use 
where CHX decreased bacterial activity and propolis maintained it (p<0.001).  
Effects of mouthwash treatments on blood pressure 
The use of CHX and propolis mouthwashes for seven days did not significantly 
change any blood pressure values when compared to baseline values or to one 
another (p>0.05; see table 2).  
Effects of mouthwash treatments on vascular function 
Figures 2 and 3 and table 3 show that using either mouthwash for seven days does 
not significantly influence the tissue oxygenation index (TOI_1) of participants at any 
point during the reactive hyperaemia tests when compared to their baseline values 
or when comparing mouthwashes (P>0.05). Figures 2 and 3 illustrate TOI_1 
percentages throughout the tests. The baseline stage of the test lasted for 120 
seconds after which the TOI_1 percentage started decreasing in the occlusion stage 
(lasting from 120 to 420 seconds). At 420 seconds the recovery stage started where 
percentage tissue oxygenation increased rapidly and slowly levelled out to baseline 
levels until the end of the test. The maximal TOI_1 value throughout the reactive 
hyperaemia test before CHX exposure was 84.4% and after was 83.9% (p=0.53). 
Before PRO exposure the maximal TOI_1 was 83.6% and after was 83.8% (p=0.80). 
Table 1. Participant baseline characteristics. 
 
 CHX PRO Total P value  
Participants (n) 14 14 28 - 
Age (years) 27 ±4.0 26 ±6.9 26 ±5.5 0.28 
Weight (kg) 63.1 ±12.0 58.6 ±7.0 60.8 ±9.9 0.24 
Height (m) 1.7 ±0.1 1.7 ±0.0 1.7 ±0.1 0.27 
BMI (kg/m2) 22.1 ±2.8 21.3 ±2.0 21.7 ±2.4 0.41 
Body fat percentage 
(%) 
22.8 ±6.1 22.7 ±7.1 22.6 ±6.4 0.95 
SBP (mmHg)  103.3 ±10.4 101.8 ±6.9 102.5 ±8.7 0.67 
DBP (mmHg) 66.0 ±7.8 60.8 ±3.9 63.4 ±6.6 0.04 
MAP (mmHg) 78.3 ±8.3 74.7 ±4.5 76.5 ±6.8 0.17 
HR (bpm) 59.5 ±11.2 62.1 ±8.9 60.8 ±10.0 0.51 
Data expressed as means ± standard deviations. CHX; antiseptic CHX based mouthwash. PRO; 
propolis mouthwash. BMI; body mass index. SBP; systolic blood pressure. DBP; diastolic blood 
pressure. MAP; mean arterial pressure. HR; heart rate. P value obtained from independent t tests 
and non-parametric Mann-Whitney U tests.  










Table 2. The ONRC and blood pressure data collected pre and post mouthwash use. 
 
 CHX PRO Difference-
s between 
CHX & PRO  
P value (C)  
 Pre  Post Difference P value 
(A) 
 













+11.5 0.71 <0.001 































-1.3 0.23 0.61 








-1.8 0.28 0.56 
Data expressed as means ± standard deviations. CHX; antiseptic CHX based mouthwash. PRO; propolis mouthwash. SBP; 
systolic blood pressure. DBP; diastolic blood pressure. MAP; mean arterial pressure. HR; heart rate. A; p value obtained 
from a paired t test on the pre and post values from CHX. B; p value obtained from a paired t test on the pre and post values 
































Figure 2. The effects of CHX mouthwash on participant’s average percentage tissue 
oxygenation during a reactive hyperaemia test. 
 
 
Figure 3. The effects of propolis mouthwash on participant’s average percentage tissue 
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This paper has demonstrated that a laboratory-made propolis mouthwash used for 
seven days twice-daily can maintain the ONRC of commensal bacteria in healthy 
individuals. It has also been found that an antiseptic CHX based mouthwash can 
significantly abolish this bacterial activity, lowering levels by 67.7% in seven days on 
average. These findings suggest that the hypotheses can be accepted regarding the 
effects of mouthwashes on bacterial ONRC.  
The main findings around ONRC from the current research relate to the nitrate-
nitrite-NO pathway and blood pressure. CHX mouthwash has anti-bacterial 
properties which are unable to differentiate between oral bacteria species. It 
therefore decreases the ability of commensal bacteria to reduce nitrate to nitrite, 
suggesting a reduction in NO production (Bryan, Tribble & Angelov, 2017). The 
literature indicates that a decreased ONRC raises blood pressure mostly likely due 
to a disruption in NO production as it is a vasodilator (Bryan, Tribble & Angelov, 
2017; Kapil et al, 2013). However, contrary to the current hypothesis, no significant 
increases in blood pressure were seen following CHX use in the current paper. CHX 
mouthwash may therefore not have affected NO production enough to influence 
participant’s vascular health. Nitrate and nitrite concentrations in the saliva and blood 
weren’t analysed in this paper so it cannot be confirmed that NO levels were directly 
reduced following a reduction in ONRC caused by CHX mouthwash. This needs 
confirmation because NO can be formed using alternative routes which may be why 
no changes in blood pressure were seen following CHX use. Nitric oxide synthase 
(NOS) enzymes combine L-arginine and oxygen to make NO. Therefore, if oxygen is 
available, this pathway may be upregulated to produce NO if the nitrate-nitrite-NO 
pathway is disrupted by using CHX mouthwash (Lundberg, Weitzberg & Gladwin, 
2008).  
Additionally, vascular function was measured using a reactive hyperaemia test whilst 
recording tissue oxygenation levels. The maximum TOI_1 percentage reflects the 
Table 3. Average tissue oxygenation index percentages recorded during the reactive 
hyperaemia tests for both mouthwashes. 
 
 CHX PRO Differences 
between CHX 
& PRO  






Pre Post Differences P value 
(B) 
Average TOI_1 









+0.1 0.94 0.75 
Minimum TOI_1 
value throughout 










-2.2 0.21 0.68 
Maximum TOI_1 
value throughout 









+0.1 0.80 0.93 
Data expressed as means ± standard deviations. CHX; antiseptic CHX based mouthwash. PRO; propolis mouthwash. 
Average TOI_1 baseline value; the first 120 seconds (2 minutes) of the reactive hyperaemia test. A; p value obtained from a 
paired t test on the pre and post values from CHX. B; p value obtained from a paired t test on the pre and post values from 
PRO. C; p value obtained from an independent t test on the differences between CHX and PRO mouthwashes. 




recovery stage where blood flow increases rapidly in the blood vessels creating a 
peak in tissue oxygenation. This sudden increase in blood flow causes shear stress 
in the vessels which stimulates NO release from endothelial cells. NO binds to 
smooth muscle in the vessel causing a decrease in muscle tension and contraction 
which dilates the vessel and allows for more blood to flow through to the tissues 
(Gerovasili et al, 2010; Sandoo et al, 2010). No significant changes to the TOI_1 
percentages following CHX mouthwash is unexpected because CHX has been 
shown to disrupt the nitrate-nitrite-NO pathway therefore indicating less NO would be 
available to dilate blood vessels. A reduction in vasodilation would produce lower 
maximum TOI_1 percentages as less blood would be travelling through the vessels 
to deliver oxygen to the tissues, decreasing vascular function. Healthy participants 
were used in the current paper who may be able to cope with an attenuated ONRC 
following CHX mouthwash use. As mentioned previously, it is possible that other 
pathways could be involved in producing NO meaning a decreased ONRC would not 
significantly influence NO levels endogenously, therefore leading to little change in 
vasodilation ability, TOI_1 percentages and vascular function as seen in the current 
study (Lundberg Weitzberg & Gladwin, 2008). Other population types with existing 
vascular issues may show different results like those with hypertension. It seems that 
no previous research has investigated the effects of mouthwashes on vascular 
function and the reactive hyperaemia test therefore the current findings cannot be 
compared with those in the literature.  
Unlike CHX mouthwash, the laboratory-made propolis mouthwash did not seem to 
disrupt oral bacteria’s ability to reduce nitrate to nitrite as it does not contain the 
same antiseptic substances. This means NO production in these mouthwash users 
remained unchanged in theory, even though other pathways for NO production do 
exist which may have altered NO concentrations as well (Lundberg Weitzberg & 
Gladwin, 2008). From this paper it seems propolis mouthwash may be less 
detrimental to oral commensal bacteria than CHX mouthwash. Although no 
significant differences were found in blood pressure, a 2.3mmHg reduction in SBP 
following propolis mouthwash use for seven days was seen (p=0.06). This reduction 
may suggest that a propolis mouthwash could potentially help lower individual’s 
SBP. This may be because the ONRC of these participants wasn’t attenuated so NO 
could act as an efficient vasodilator by counteracting rises in blood pressure (Stauss 
& Persson, 2000). However, no literature seems to be available to confirm these 
findings around propolis mouthwash and more participants are needed to verify 
whether this result will be significant.  
In the current literature, Petersson et al (2009) found significant reductions in the 
ONRC of rats when their oral cavities were sprayed with Corsodyl mouthwash 
containing CHX for seven days. This paper supports the current research findings in 
relation to the effects of CHX mouthwash on ONRC despite being conducted in rats 
which may raise generalisation issues when applied to humans. Kapil et al (2013) 
conducted a similar study in humans and found a 90% reduction in ONRC following 
CHX mouthwash use for seven days which further supports the current findings. 
However, they also found a significant rise in participant’s blood pressure due to a 
disruption in nitrite homeostasis and NO production which failed to be seen in the 
current paper. This may be because they used several measures of blood pressure 
throughout the trial period including clinical, home and twenty-four-hour ambulatory 
blood pressure monitoring. In comparison, the current study obtained blood pressure 
readings before and after the seven day trial, not throughout the trial, at night or at 
home. Perhaps more readings are needed to provide a more sensitive measurement 




in the current paper. Furthermore, Kapil et al (2013) used a cross over study design 
where participants acted as their own controls by having measures taken during a 
mouthwash trial and a control trial. This eliminates the possibility of any baseline 
blood pressure differences causing variation in results unlike in the current study 
which had significant differences in baseline DBP between participants in different 
mouthwash groups. Methodological issues in the present study could be leading to 
insignificant blood pressure results in the CHX group causing discrepancies with the 
existing literature. It seems that more robust protocols exist within the literature and 
that the current protocol could be improved based on this. 
The preservation of salivary ONRC following the use of propolis mouthwash may 
have implications in dentistry and vascular health. If the current laboratory-made 
propolis mouthwash is shown to have anti-bacterial properties against harmful oral 
pathogens, then it would possess the same properties as popular antiseptic 
mouthwashes yet preserve the actions of commensal bacteria which have an 
important role in vascular homeostasis. Therefore, propolis mouthwash would be 
less detrimental to an individual’s oral microbiome and blood pressure control 
compared to commercial CHX mouthwashes. As mentioned previously, propolis 
mouthwashes have shown anti-bacterial potential comparable to CHX mouthwashes 
(Dodwad & Kukreja, 2011; Khurshid et al, 2017). However, in some of these 
commercial propolis mouthwashes, the solutions contain other substances like 
menthol which have their own anti-bacterial properties that may not preserve the 
ONRC of oral bacteria like this mouthwash does (Pattnaik et al, 1997). Therefore, 
the anti-bacterial properties of the current propolis mouthwash containing only 
propolis and water need to be verified. Furthermore, the borderline significant 
reduction in SBP following propolis mouthwash use may imply this mouthwash could 
be an effective therapeutic for lowering SBP in those with hypertension.  
Although the findings from this research present potential implications, some 
methodological issues should be considered. A limited time frame for conducting this 
study meant a small sample was gathered, raising issues with generalising findings 
to a wider population of mouthwash users. Furthermore, a limited number of 
participants gives less statistical power to measures which may suggest why no 
significant differences in blood pressure or tissue oxygenation were found following 
mouthwash use. However, Kapil et al (2013) included nineteen participants and 
found significant blood pressure changes following CHX mouthwash use which was 
less than in the current paper suggesting insignificant values were due to other 
factors as discussed previously. Some participants reported missing mouthwash 
tubes throughout the trial indicating poor adherence to the study protocol. As these 
individuals wouldn’t have used as much mouthwash as those using all tubes, their 
changes in ONRC, NO production and therefore blood pressure and tissue 
oxygenation levels after the study may be different leading to high participant 
variation. Another point to highlight is that participants used mouthwashes for seven 
days. It is questionable whether this time frame is long enough to observe sufficient 
changes in the parameters measured. However, there is evidence to suggest that 
the microbiome can rapidly adapt to new stimuli. A change in diet can alter the gut 
microbiome one day after it has reached the distal gut microbiota (David et al, 2014). 
This suggests that oral commensal bacteria may respond to mouthwash rapidly 
which explains why a significant reduction in ONRC from CHX mouthwash was 
observed. Having said this, a rapid change in commensal bacteria action doesn’t 
explain why blood pressure values weren’t significantly altered following CHX 
mouthwash in this study. Measuring blood pressure is highly variable and is 




influenced by many factors such as the time of day (Lemmer, 1989) and 
psychological factors like the mood of an individual (Pollard & Schwartz, 2003). This 
indicates that blood pressure may be influenced by variables other than ONRC and 
NO production whilst measures were taken.  
This paper highlights that further investigation into blood pressure and vascular 
function using hypertensive individuals would be valuable. Bondonno et al (2014) 
found that hypertensive individuals aged 65 years using a CHX based mouthwash 
for three days had a significantly reduced ONRC, salivary nitrite concentration and 
increased SBP values. This confirms that a disruption to bacterial NO production 
following CHX mouthwash is detrimental to blood pressure in those with 
hypertension but perhaps not for those with healthy values as shown by no 
significant blood pressure changes in the current findings. For those with 
hypertension, a reduction in blood pressure would be beneficial to their health and 
potentially prevent the development of diseases like heart disease. The preserved 
ONRC effect and almost significant reduction in SBP seen following propolis 
mouthwash use may lead to an improved NO production and normalised blood 
pressure in hypertensive individuals that could be clinically significant. In terms of 
vascular function, hypertension is associated with endothelial dysfunction and 
disrupted NO production in the vessels (Napoli et al, 2006; Sandoo et al, 2010). No 
significant changes to tissue oxygenation values were seen in the current findings 
following mouthwash use however, changes may be more likely in hypertensive 
individuals because their NO levels are already disrupted. Further disruption to NO 
production following CHX mouthwash in these individuals may attenuate blood flow 
to the tissues in the recovery phase of the reactive hyperaemia test due to less 
vasodilation and therefore less oxygen delivery to the tissues. This could cause 
significantly lower maximum TOI_1 percentages compared to the healthy 
participants who showed no differences following CHX use in the current paper. 
Future work should include analysing nitrate and nitrite concentrations in saliva and 
plasma samples which couldn’t be included here due to time restrictions. This would 
clarify whether alterations to the nitrate-nitrite-NO pathway from mouthwashes 
translate into altered nitrite and NO concentrations endogenously. This is especially 
important as Burleigh et al (2018) have observed that increases in nitrate-reducing 
bacteria number and ONRC are associated with increases in salivary nitrite but not 
plasma nitrite which is the most accurate biomarker to indicate NO bioavailability. As 
plasma nitrite levels do not seem to be directly increased by bacterial ONRC, NO 
production may not be either which highlights another possibility as to why blood 
pressure and tissue oxygenation values weren’t significantly influenced by 
mouthwashes. Lastly, it would be interesting to determine the anti-bacterial 
properties of the laboratory-made propolis mouthwash as this could have potential 
uses in dentistry as mentioned previously.  
Conclusions 
The current paper has addressed its aims by demonstrating that a laboratory-made 
propolis mouthwash can indeed maintain the ONRC of commensal bacteria when 
compared with a CHX based mouthwash. The mouthwashes can affect the activity of 
nitrate-reducing bacteria very differently. Propolis mouthwash’s preservation of 
bacterial ONRC has potential implications as a therapeutic for hypertension and in 
dentistry as it is shown to be less detrimental to the oral microbiome than 
commercial CHX based mouthwashes. No significant effects of mouthwashes on 




blood pressure or vascular function were found which causes some disagreements 
with the existing literature. Discrepancies may be down to methodological limitations 
in the current study or physiological mechanisms which may work to stabilise NO 
values endogenously despite ONRC changes. Further work is therefore needed to 
assess why these discrepancies occurred and to verify the potential uses of propolis 
mouthwash in relation to dentistry and health.  
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